enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Dry eye syndrome - Wikipedia

   en.wikipedia.org/wiki/Dry_eye_syndrome

   The McMonnies & Ho dry eye questionnaire is often used in clinical studies of dry eyes. [29] Some tests allow patients to be classified into one of two categories, "aqueous-deficient" or "hyperevaporative". Diagnostic guidelines were published in 2007 by the Dry Eye Workshop, [30] updated by the Dry Eye Workshop II in 2017. [31]

3. Xerophthalmia - Wikipedia

   en.wikipedia.org/wiki/Xerophthalmia

   Xerophthalmia (from Ancient Greek xērós (ξηρός) meaning "dry" and ophthalmos (οφθαλμός) meaning "eye") is a medical condition in which the eye fails to produce tears. It may be caused by vitamin A deficiency, [1] which is sometimes used to describe that condition, although there may be other causes.

4. Conjunctivochalasis - Wikipedia

   en.wikipedia.org/wiki/Conjunctivochalasis

   Conjunctivochalasis, also known as mechanical dry eye (MDE), is a common eye surface condition characterized by the presence of excess folds of the conjunctiva located between the globe of the eye and the eyelid margin.

5. Artificial tears - Wikipedia

   en.wikipedia.org/wiki/Artificial_tears

   Artificial tears are lubricating eye drops used to relieve dryness and irritation of the ocular surface. [1] Dry eye syndrome (keratoconjunctivitis sicca) is a common ocular surface disorder and is characterized by disruption of the tear film and increased inflammation.

6. Schirmer's test - Wikipedia

   en.wikipedia.org/wiki/Schirmer's_test

   This test may be especially valuable for patients with dry eyes since it can point to specific treatment strategies for dry eye. The tears may also be examined for their content of lysozyme, an enzyme normally found in tears. Another test involves fluorescein eye drops, which contain a dye that is placed in the eye. The dye should drain with ...

7. Oyster Point's drug becomes first FDA-approved nasal ... - AOL

   www.aol.com/finance/fda-approves-oyster-points...

   Oyster Point said Tyrvaya, a twice daily nasal spray, was tested in a late-stage and two mid-stage trials covering over 1,000 patients with mild, moderate or severe symptoms of dry eye disease (DED).